In addition to providing a real-time readout of CD8 T cells at the tumor site, CD8-specific T cell-based PET imaging agents may also be able to capture systemic changes in CD8 T cell localization in response to ICI therapy. The gene discussed is CD8A; the disease is neoplasm.